好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Ultra High-field MRI Versus 1.5/3 T MRI in the Detection of Cerebrovascular Disease
Cerebrovascular Disease and Interventional Neurology
P15 - Poster Session 15 (5:30 PM-6:30 PM)
13-005

To compare the efficacy of 7-Tesla (7T) versus 1.5T and 3T in the diagnosis and management of cerebrovascular disease.

Given the 2017 FDA approval of 7T MRI for clinical use, it is urgently necessary to establish the cerebrovascular conditions and diagnostic questions best addressed by MRI instruments that utilize 7T compared to lower field systems at 1.5T and 3T. 

A systematic search following PRISMA (Preferred Reporting for Systematic Reviews and Meta-Analysis) guidelines was performed on PubMed and Web of Science with a pre-planned search strategy, which yielded 368 reports after removing duplicates. When imposing a selection criteria that included direct comparison of 1.5/3T versus 7T for cerebrovascular disease, 20 studies remained. For meta-analysis, we utilized the metafor package on R.
In 20 studies, there are 387 total patients where atherosclerosis, arteriovenous malformation, and aneurysm are the most examined pathologies. Three studies reported the mean number and variance of lesions per patient comparing low-field and 7T imaging. 7T MRI showed a pooled effect of 2.49 more lesions (SMD, 95% CI: 0.38-4.61, p <0.05) using a random-effects model. From seven studies that reported the aggregated number of lesions instead of lesions per patient, 7T identified 0.8 more lesions (95% CI: 0.12-1.48, p <0.05), demonstrating the superiority of 7T imaging in detecting lesions when compared to 1.5T/3T imaging. Seven of the studies utilized the same MRI sequences in the low-field and high-field scans, and 13 studies ran at least one distinct experiment at one of the field strengths.
MRI can detect more cerebrovascular lesions at 7T compared to at lower-field. More studies are needed to establish 7T systems as the preferred approach to show the extent and location of cerebrovascular disease. Future studies may also demonstrate superior 7T characterization of inflammation as a key role in determining risk of cerebral ischemia or hemorrhage.
Authors/Disclosures
David T. Krist
PRESENTER 		Mr. Krist has nothing to disclose.
Rachael Tessem Ms. Tessem has nothing to disclose.
No disclosure on file
Tracy Kao Miss Kao has nothing to disclose.
No disclosure on file
Wael Ali Mostafa Wael Ali Mostafa has received personal compensation for serving as an employee of Carle Health. The institution of Wael Ali Mostafa has received research support from NICO.
No disclosure on file
No disclosure on file
No disclosure on file